News | June 26, 2026
Eli Lilly seals Centessa acquisition as it bets big on next-gen sleep disorder drugs
Centessa is a clinical-stage biotech focused on developing orexin receptor 2 agonists
Centessa is a clinical-stage biotech focused on developing orexin receptor 2 agonists
BOTOX Cosmetic is providing participants with training resources, mentorship, and— for 20 selected founders— access to business-boosting capital
Health ministry notifies amendments to the Drugs Rules, 1945 to expand the ambit of Schedule H2 and bring additional categories of drugs under the QR Code-based track and trace framework
Backed by Phase 3 trial showing 24% lower risk of progression
The offer is being made through Harmony Row Acquisition Co., a wholly owned GSK subsidiary, and targets all outstanding Class A and Class B shares of Nuvalent
The company emphasized that its mRNA system is built on three pillars—mRNA science, delivery science, and manufacturing processes
The appointments come as Andrew Paterson, who has spent 31 years with the company, prepares to retire
In his new role, he will lead the company's growth strategy across Africa, strengthen healthcare partnerships, and expand access to innovative diagnostic solutions
Awalgaonkar's cross-industry expertise positions him to further strengthen the company's procurement capabilities and support its long-term growth strategy
Partnership with Sunshine Healthcare aims to build local pharmaceutical capabilities and strengthen supply chain resilience
Subscribe To Our Newsletter & Stay Updated
